Invasive Malignant Neoplasm — Trials

Invasive Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,820 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 604
Recruiting: 302
Ph III recruiting: 36
Growth YoY: +27.2%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (283)

clinicaltrialsPublishedShowing 51–100 of 780 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04266249	CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy	active not recruiting	Phase 2	2,175	ECOG-ACRIN Cancer Research GroupNETWORK	2	Sep 14, 2026	clinicaltrials
NCT05710328	Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial	active not recruiting	Phase 2	235	ECOG-ACRIN Cancer Research GroupNETWORK	2	Sep 14, 2026